Skip to content
Catalyst

CHEBI:15765Papers

Papers about CHEBI:15765

papers
68
33 years, by papers

Newest first

51 to 68 of 68

Every paper here, unless its row says otherwiseIndexed under CHEBI:15765 in PubMed's chemical list

  • Effects of gabapentin on the motor response to levodopa: a double-blind, placebo-controlled, crossover study in patients with complicated Parkinson disease.

    Clinical neuropharmacology2004PMID 15190235

  • Gabapentin versus levodopa for the treatment of Restless Legs Syndrome in hemodialysis patients: an open-label study.

    Renal failure2004PMID 15462107

  • Levodopa and the progression of Parkinson's disease.

    The New England journal of medicine2004PMID 15590952Tests CHEBI:15765

  • Long-term outcome of quetiapine use for psychosis among Parkinsonian patients.

    Movement disorders2003PMID 12722164

  • Levodopa improves physical fatigue in Parkinson's disease: a double-blind, placebo-controlled, crossover study.

    Movement disorders2003PMID 14534913Tests CHEBI:15765

  • Quetiapine for psychosis in Parkinson's disease versus dementia with Lewy bodies.

    The Journal of clinical psychiatry2002PMID 12088163

  • The effect of quetiapine on psychosis and motor function in parkinsonian patients with and without dementia.

    Movement disorders2002PMID 12210856

  • Quetiapine for the treatment of drug-induced psychosis in Parkinson's disease.

    Movement disorders1999PMID 10348474

  • Actions of adenosine A2A receptor antagonist KW-6002 on drug-induced catalepsy and hypokinesia caused by reserpine or MPTP.

    Psychopharmacology1999PMID 10591873

  • Improvement of levodopa-induced dyskinesia by propranolol in Parkinson's disease.

    Neurology1996PMID 8649546

  • Screening test for growth hormone deficiency: usefulness of L-dopa-propranolol provocative test.

    Journal of paediatrics and child health1994PMID 7946545Also indexed under CHEBI:15765 as a PubMed major topic

  • Progression after chronic manganese exposure.

    Neurology1993PMID 8351000

  • Pharmacologic maintenance of abstinence in patients with alcoholism: no efficacy of 5-hydroxytryptophan or levodopa.

    Clinical pharmacology and therapeutics1992PMID 1424429Also compares against CHEBI:15765

  • Neuroleptic-induced catalepsy as a model of Parkinson's disease. I. Effect of dopaminergic agents.

    Journal of neural transmission1990PMID 1977409

  • Blindness impairs plasma growth hormone response to L-dopa but not to arginine.

    The Journal of clinical endocrinology and metabolism1990PMID 2318945

  • Growth hormone (GH) responses to arginine and L-dopa alone and after GHRH pretreatment.

    Clinical endocrinology1988PMID 3145820

  • L-5-hydroxytryptophan alone and in combination with a peripheral decarboxylase inhibitor in the treatment of depression.

    Neuropsychobiology1988PMID 3265988

  • Reversal of ethanol intoxication in humans: an assessment of the efficacy of L-dopa, aminophylline, and ephedrine.

    Psychopharmacology1977PMID 414280

← Previous 50